Research Archives - Page 28 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 9 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
Sparrow Health System has chosen Mayo Medical Laboratories as its primary reference laboratory for advanced laboratory testing, enhancing the availability of complex tests and making test results available more quickly to providers and...
Mayo Medical Laboratories and National University Hospital (NUH) in Singapore are now electronically linked via the widely used and secure Health Level 7 interface, enabling NUH to order specialized Mayo laboratory tests and receive patient...
Pathways Case Studies: November 2019 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cytogenetics, Genetics,...
Pathways Case Studies: May 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Bone and Soft Tissue & Infectious...
September 2023 - Cytogenetics & Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cytogenetics & Hematopathology.
Learn more about how carrier screening at Mayo Clinic Laboratories can provide prospective parents with a personalized risk assessment of bearing a child with certain inherited conditions.
Novel panel identifies toxins linked to asthma and GI diseases - Insights
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...